497 related articles for article (PubMed ID: 30119236)
1. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
Wang H; Li H; Zhang L; Yang D
Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
[TBL] [Abstract][Full Text] [Related]
2. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
Gao R; Fang C; Xu J; Tan H; Li P; Ma L
Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
[TBL] [Abstract][Full Text] [Related]
3. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis.
Li L; Shang J; Zhang Y; Liu S; Peng Y; Zhou Z; Pan H; Wang X; Chen L; Zhao Q
Oncol Rep; 2017 Sep; 38(3):1383-1392. PubMed ID: 28731151
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate ischemic neuronal death by targeting miR-21/PDCD4 signaling pathway.
Yan H; Rao J; Yuan J; Gao L; Huang W; Zhao L; Ren J
Cell Death Dis; 2017 Dec; 8(12):3211. PubMed ID: 29238035
[TBL] [Abstract][Full Text] [Related]
5. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
Wu YZ; Lin HY; Zhang Y; Chen WF
J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
[TBL] [Abstract][Full Text] [Related]
6. MiR-503 promotes the migration and invasion of colorectal cancer cells by regulating PDCD4.
Li L; Zhang X; Yi Z; Liang X; Yin W; Li S
J BUON; 2018; 23(3):579-586. PubMed ID: 30003722
[TBL] [Abstract][Full Text] [Related]
7. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z
Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111
[TBL] [Abstract][Full Text] [Related]
8. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
Liang H; Xu Y; Zhang Q; Yang Y; Mou Y; Gao Y; Chen R; Chen C; Dai P
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):725-736. PubMed ID: 30861353
[TBL] [Abstract][Full Text] [Related]
9. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer.
Zeng ZL; Lu JH; Wang Y; Sheng H; Wang YN; Chen ZH; Wu QN; Zheng JB; Chen YX; Yang DD; Yu K; Mo HY; Hu JJ; Hu PS; Liu ZX; Ju HQ; Xu RH
Cancer Med; 2021 Apr; 10(7):2423-2441. PubMed ID: 33666372
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of maternally expressed gene 3 attenuated lipopolysaccharide-induced apoptosis through sponging miR-21 in renal tubular epithelial cells.
Yang R; Liu S; Wen J; Xue L; Zhang Y; Yan D; Wang G; Liu Z
J Cell Biochem; 2018 Sep; 119(9):7800-7806. PubMed ID: 29923218
[TBL] [Abstract][Full Text] [Related]
11. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
12. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
13. IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 inhibition.
Tong D; Zou E; Bai L; Ma J; Guo N; Wang H; Jiang L
J BUON; 2020; 25(5):2205-2214. PubMed ID: 33277837
[TBL] [Abstract][Full Text] [Related]
14. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p.
Ghanbarian M; Afgar A; Yadegarazari R; Najafi R; Teimoori-Toolabi L
Biomed Pharmacother; 2018 Dec; 108():1070-1080. PubMed ID: 30372807
[TBL] [Abstract][Full Text] [Related]
15. miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.
Xu K; Chen G; Qiu Y; Yuan Z; Li H; Yuan X; Sun J; Xu J; Liang X; Yin P
Oncotarget; 2017 Mar; 8(13):21719-21732. PubMed ID: 28423513
[TBL] [Abstract][Full Text] [Related]
16. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
[TBL] [Abstract][Full Text] [Related]
17. TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis.
Li C; Gao Y; Li Y; Ding D
Biochem Biophys Res Commun; 2017 Sep; 491(2):552-557. PubMed ID: 28302487
[TBL] [Abstract][Full Text] [Related]
18. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
Liang J; Tian XF; Yang W
World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
[TBL] [Abstract][Full Text] [Related]
19. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.
Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S
Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]